20^th European Gastroenterology and Therapeutics Congress

Colorectal Cancer: Prevention, Screening, and Treatment

Colorectal cancer (CRC) is one of the most prevalent and preventable malignancies worldwide. This session addresses current trends in the prevention, early detection, and treatment of CRC, emphasizing the importance of timely screening and risk stratification. Colonoscopy remains the gold standard for CRC screening, but advancements in non-invasive methods such as stool DNA tests, FIT, and liquid biopsies are expanding accessibility and compliance. Genetic testing and molecular profiling are refining risk assessment, enabling earlier interventions and personalized treatment strategies. Minimally invasive surgical techniques, immunotherapy, and targeted agents like EGFR and VEGF inhibitors have transformed the therapeutic landscape, improving survival rates even in advanced disease. The session also covers hereditary syndromes like Lynch syndrome and FAP, with recommendations for surveillance and prophylactic measures. By integrating public health strategies, patient education, and cutting-edge research, CRC prevention and treatment continue to evolve, aiming for earlier detection and better long-term outcomes.